TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Neurotrauma Research Sweden Nrs AB
Closing information (x1000 DKK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
310
|
317
|
490 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-84
|
-120
|
3,749 |
| EBITDA |
-67
|
-101
|
256 |
| Total assets |
4,606
|
4,921
|
5,533 |
| Current assets |
73
|
230
|
392 |
| Current liabilities |
205
|
140
|
23 |
| Equity capital |
4,401
|
4,782
|
5,510 |
| - share capital |
63
|
66
|
72 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
95.5%
|
97.2%
|
99.6% |
| Turnover per employee |
310
|
317
|
490 |
| Profit as a percentage of turnover |
-27.1%
|
-37.9%
|
765.1% |
| Return on assets (ROA) |
-1.8%
|
-2.4%
|
67.8% |
| Current ratio |
35.6%
|
164.3%
|
1704.3% |
| Return on equity (ROE) |
-1.9%
|
-2.5%
|
68.0% |
| Change turnover |
4
|
-130
|
-72 |
| Change turnover % |
1%
|
-29%
|
-13% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.